01-10-2017 | Letter To The Editor
Future Applications of the Selective Prostacyclin (IP) Receptor Agonist Selexipag in Pediatric Pulmonary Hypertension
Published in: Pediatric Cardiology | Issue 7/2017
Login to get access01-10-2017 | Letter To The Editor
Published in: Pediatric Cardiology | Issue 7/2017
Login to get access